Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0009766
Disease: Allergic Conjunctivitis
Allergic Conjunctivitis
0.010 Biomarker BEFREE Quercetin inhibited the ovalbumin (OVA) induced expression of IgE, HA, IL-4, TNF-α and substance-P in the peripheral blood of AC mouse models. 31672514

2020

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0399452
Disease: Supragingival dental plaque
Supragingival dental plaque
0.010 Biomarker BEFREE Subjective pain (assessed by visual analogue scale in pain diary and by chairside archwire activation), periodontal status (assessed by periodontal clinical parameters), cytokines in gingival crevicular fluid (interleukin 1β, prostaglandin E<sub>2</sub>, substance P) and periodontopathic bacteria (Porphyromonas gingivalis and Treponema denticola) in supragingival plaque were assessed. 31833004

2020

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
Postmenopausal frontal fibrosing alopecia
0.010 AlteredExpression BEFREE We then quantitatively assessed and compared SP and CGRP expression from control, LPP and FFA scalp biopsies. 30408256

2020

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C1557335
Disease: Ocular surface disease
Ocular surface disease
0.010 Biomarker BEFREE Neuroinflammation plays an important role in the pathogenesis of ocular surface disease, including dry eye disease (DED), but little is known about the contribution of substance P (SP) to DED. 31669306

2020

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C4255374
Disease: Frontal fibrosing alopecia
Frontal fibrosing alopecia
0.010 AlteredExpression BEFREE We then quantitatively assessed and compared SP and CGRP expression from control, LPP and FFA scalp biopsies. 30408256

2020

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0002895
Disease: Anemia, Sickle Cell
Anemia, Sickle Cell
0.010 Biomarker BEFREE <b>Materials and methods:</b> Humanized mouse model with SCD defined as moderate- and non-responders to EA were intraperitoneally administered with antagonist of SP receptor NK1R (netupitant, 10 mg/kg/day, i.p.) or p38 MAPK inhibitor (SB203580, 10 mg/kg/day, i.p.) alone or in combination with EA (acupoint GB30, every 3rd day until day 12). 31447579

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0005956
Disease: Bone Marrow Diseases
Bone Marrow Diseases
0.010 Biomarker BEFREE The immunohistochemical investigation revealed that substance P-positive nerve fibers were obviously increased in number and deeply ingrown into the inner anulus fibrosus and even into the nucleus pulposus in the degenerative cervical discs of patients with severe neck pain in comparison with the discs of patients with cervical spondylotic radiculopathy or myelopathy and normal control discs (P<0.01). 30848823

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0010692
Disease: Cystitis
Cystitis
0.010 Biomarker BEFREE To identify the effects of the neurokinin-1 receptor (NK1R) antagonist aprepitant in treating pelvic pain, micturition symptoms, and bladder inflammation in mice with experimental autoimmune cystitis (EAC) similar to bladder pain syndrome/interstitial cystitis (BPS/IC). 30196377

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0011644
Disease: Scleroderma
Scleroderma
0.010 Biomarker BEFREE The objective of this case report is to highlight the potential use of a substance P antagonist in the treatment of scleroderma associated nausea. 31119781

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
Fenestration (morphologic abnormality)
0.010 Biomarker BEFREE This study aimed to investigate whether CSE/H<sub>2</sub>S regulates SP and the neurokinin-1 receptor (NK-1R) andmodulates fenestrations in LSECs following caecalligation and puncture (CLP)-induced sepsis. 31261857

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0018213
Disease: Graves Disease
Graves Disease
0.010 Biomarker BEFREE GD = Graves disease; hCG = human chorionic gonadotropin; MMI = methimazole; PPT = postpartum thyroiditis; PTU = propylthiouracil; T3 = triiodothyronine; T4 = thyroxine; TBG = thyroxine-binding globulin; TRAb = TSH receptor antibody; TSH = thyroid-stimulating hormone. 30289300

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 Biomarker BEFREE Therefore, in the present study, using the immunofluorescence technique, we first examined the influence of hyperglycemia on the NOS- containing neurons in the porcine small intestine and secondly the co-localization of nNOS with vasoactive intestinal polypeptide (VIP), galanin (GAL) and substance P (SP) in all plexuses studied. 30987291

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0021933
Disease: Intussusception
Intussusception
0.010 AlteredExpression BEFREE Serum SP levels in patients with acute intussusception were significantly higher than those in controls. 31006358

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.010 AlteredExpression BEFREE Although initiation and resolution of inflammation is an important component of cellular injury and repair in renal disease, it is unknown whether CTS activation of NKA α-1 signaling in this setting regulates this inflammatory response. 31132948

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.010 Biomarker BEFREE Taken together, these findings suggest that Neurokinin-1 receptor antagonists suppress leukemic cell growth and may be considered to be potential antitumor drugs for the treatment of human acute myeloid leukemia. 29721755

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0024031
Disease: Low Back Pain
Low Back Pain
0.010 AlteredExpression BEFREE The results of paw/foot withdrawal threshold and qRT-PCR indicated that P. acnes-inoculated rats had obvious LBP in behavioral evaluation and over-expression of substance P (SP) and calcitonin gene-related peptide (CGRP) in IVDs. 30397790

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.010 Biomarker BEFREE Neurokinin-1 receptor antagonists have been investigated with variable benefit in CKDaP, solid tumors and lymphoproliferative disorders such as cutaneous T-cell lymphoma, Sézary syndrome. 31452276

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 Biomarker BEFREE These data suggested that PAR2, possibly via 12-LOX, activates TRPV1 and leads to CGRP and substance P release to prevent I/R injury in the heart, indicating that the 12-LOX-TRPV1 pathway conveys cardiac protection to alleviate myocardial infarction. 31602241

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0027121
Disease: Myositis
Myositis
0.010 Biomarker BEFREE <b>Purpose/Aim</b>: Substance P-NK-1R signaling has been implicated in fibrotic tendinopathies and myositis. 31443618

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0027765
Disease: nervous system disorder
nervous system disorder
0.010 Biomarker BEFREE We also uncover the mechanisms of the neurokinin 1 receptor involved in neurological disorder and various methods of modulating the neurokinin 1 receptor, which may result in therapeutic action. 30260793

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0035127
Disease: Cumulative Trauma Disorders
Cumulative Trauma Disorders
0.010 Biomarker BEFREE Blocking this signaling with a neurokinin 1 receptor antagonist (NK1RA) has been proposed as a therapeutic target for their treatment.<b>Materials and Methods</b>: Using a rodent model of overuse injury, we pharmacologically blocked Substance P using a specific NK1RA with the hopes of reducing forelimb tendon, muscle and dermal fibrogenic changes and associated pain-related behaviors. 31443618

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0036421
Disease: Systemic Scleroderma
Systemic Scleroderma
0.010 Biomarker BEFREE The objective of this case report is to highlight the potential use of a substance P antagonist in the treatment of scleroderma associated nausea. 31119781

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0036920
Disease: Sezary Syndrome
Sezary Syndrome
0.010 Biomarker BEFREE Neurokinin-1 receptor antagonists have been investigated with variable benefit in CKDaP, solid tumors and lymphoproliferative disorders such as cutaneous T-cell lymphoma, Sézary syndrome. 31452276

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0037274
Disease: Dermatologic disorders
Dermatologic disorders
0.010 Biomarker BEFREE Aprepitant is a neurokinin 1 receptor (NK1R) antagonist used for its antipruritic properties in dermatoses and systemic diseases.The mode of action is still unclear. 31442331

2019

Entrez Id: 6863
Gene Symbol: TAC1
TAC1
CUI: C0037928
Disease: Spinal Cord Diseases
Spinal Cord Diseases
0.010 Biomarker BEFREE The immunohistochemical investigation revealed that substance P-positive nerve fibers were obviously increased in number and deeply ingrown into the inner anulus fibrosus and even into the nucleus pulposus in the degenerative cervical discs of patients with severe neck pain in comparison with the discs of patients with cervical spondylotic radiculopathy or myelopathy and normal control discs (P<0.01). 30848823

2019